UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $208,000 | -96.4% | 12,353 | -96.7% | 0.00% | -96.4% |
| Q2 2021 | $5,781,000 | -52.0% | 378,338 | -38.9% | 0.11% | -59.6% |
| Q1 2021 | $12,042,000 | -18.4% | 618,718 | -24.5% | 0.27% | -31.1% |
| Q4 2020 | $14,750,000 | -10.1% | 819,682 | -9.1% | 0.40% | -42.5% |
| Q3 2020 | $16,405,000 | -26.3% | 901,979 | +0.5% | 0.69% | -27.1% |
| Q2 2020 | $22,251,000 | +44.6% | 897,464 | +1.6% | 0.94% | +20.9% |
| Q1 2020 | $15,390,000 | -44.4% | 883,468 | +5.8% | 0.78% | -32.5% |
| Q4 2019 | $27,663,000 | +78.8% | 834,739 | +22.6% | 1.16% | +57.7% |
| Q3 2019 | $15,475,000 | – | 680,732 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |